US OptionsDetailed Quotes
TZOO241220P12500
- 0.15
- 0.000.00%
15min DelayTrading Nov 21 12:41 ET
0.00High0.00Low
0.00Open0.15Pre Close0 Volume32 Open Interest12.50Strike Price0.00Turnover119.63%IV36.86%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type-0.0523Delta0.0177Gamma130.40Leverage Ratio-0.0130Theta-0.0007Rho-6.81Eff Leverage0.0054Vega
Travelzoo Stock Discussion
looks good eps beats estimates may be money double opportunity
Travelzoo presents a prominent swing trading opportunity which is due to recent earnings, positive news catalysts, and the proximity to its 52-week high. The company's financials indicate profitability with a strong cash flow and a healthy balance sheet, further reinforced by a positive sentiment towards its stock. It's evident from recent price targets being raised by analysts alongside strategic decisions like stock buyback programs to enhance shareholder value. Despite o...
• $Allstate (ALL.US)$: Raymond James Upgrades to Strong Buy from Outperform - PT $165 (from $145)
• $DigitalBridge Group (DBRG.US)$: JPMorgan Upgrades to Neutral from Underweight - PT $7
• $Garmin (GRMN.US)$: BofA Securities Upgrades to Buy from Neutral - PT $140 (from $165)
• $Guidewire Software (GWRE.US)$: JMP Securities Upgrades to Market Outperform from Market Perform - PT $110
• $MongoDB (MDB.US)$: UBS Upgrades to Buy from Neutral - PT $450 (from $345)...
Sometimes I like to go through the biggest losers of the day and pick out the diamonds in the rough I just had a bad day.
$Aarons Holdings Co Inc (AAN.US)$ diamond in the rough
$Baudax Bio (BXRX.US)$
$Esperion Therapeutics (ESPR.US)$
$Proteostasis Therapeutics (PTI.US)$
No comment yet